As U.S. eases cannabis curbs, firms may get access to IPOs and private funding

InfoVera Team May 1, 2026 1 minute read

<!–[if IE 9]>

<![endif]–>

The government also plans to quickly reclassify marijuana broadly, a potential boon for companies that sell for recreational use and have contended with a weak consumer spending climate and competition from illegal sellers. File.
| Photo Credit: Reuters

Companies developing cannabis-based medicines say U.S. moves to loosen restrictions on the drug could unlock private funding and the public markets, providing a lifeline to the struggling cannabis industry.

The U.S. Department of Justice last week rescheduled FDA-approved medicines and state-regulated medical marijuana products, making it easier for companies to bank and receive tax credits and deductions.

Published – May 01, 2026 10:59 am IST

Source link